📰 Pharmacy Compounding News
Page 4 - Pharmacy Compounding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharmacy Compounding. Real-time updates on events, politics, business and more.
July 7, 2022
As Novo Nordisk's Wegovy faces shortages, compounders step in to fill the gap, alarming doctors
June 30, 2022
Capital punishment practices across the U.S. continue to shift since the June 29, 1972, Supreme Court decision finding that capital punishment was often imposed discriminatorily and inconsistently.
June 22, 2022
NCPA members Cheri Garvin and Steven Hoffart made statements at the FDA’s annual drug compounding listening session on June 17. This listening session was an opportunity for stakeholders to voice their views on compounding to the FDA.
April 1, 2022
Toronto, ON (PRWEB) April 01, 2022 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical
February 10, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
January 12, 2022
USP has proposed restrictions on beyond-use dates for many compounded medications — restrictions that may complicate your ability to treat patients. That’s why NCPA and the Alliance for Pharmacy Compounding are co-hosting a FREE 30-minute virtual briefing for prescribers on Thursday, Jan. 20, on USP’s proposed changes. The aim is to make sure physicians, physician assistants, and nurse practitioners understand what’s at stake in terms of patient access to compounded meds – and are equi...
October 22, 2021
Created in 2021, this PCCA award recognizes the women and men passionately advocatingfor compounding....
October 20, 2021
Amazon is accused of promoting its own products against others sold on its online platform.
April 30, 2021
Share this article Share this article ALEXANDRIA, Va., April 30, 2021 /PRNewswire/ -- A 2020 FDA-funded report published by the National Academies of Sciences, Engineering, and Medicine (NASEM) on the safety and utility of compounded hormones is compromised by potential bias, conflicts of interest and bad science—so says an independent, third-party analysis of the NASEM report released today. The Food and Drug Administration (FDA) touted the NASEM report, which recommended restrictions on co...
April 23, 2021
NCPA April 23, 2021 If your pharmacy does compounding, the Alliance for Pharmacy Compounding wants your opinion. They’re doing a 10-minute survey on practice areas, the scope of your compounding (and how that has changed), the size of your business, and similar areas, as well as basic demographics. The survey is conducted with support from Letco Medical, Medisca, and PCCA and will inform policymakers, media, and advocacy efforts. Please take the survey no...